NewsBenzingaCanaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44 Canaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44 Benzinga 2026.10.29 22:08 (GMT+0) Open on Benzinga Other news Amazon, SanDisk, Reddit, Rivian and Intel: Why These 5 Stocks Are on Investors' Radars Today Xcel Energy Inc. (XEL) Q3 2026 Earnings Call Transcript Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript Silicom Ltd. (SILC) Q3 2026 Earnings Call Transcript DXC Technology Company (DXC) Q2 2027 Earnings Call Transcript Crocs Stock: International Sales Growth Is Offsetting U.S. Weakness (NASDAQ:CROX)
